Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Correction

Published on 16 Jan 2024

Corrigendum: Plasma exchange for two patients with autoimmune GFAP astrocytopathy with rapid progression to respiratory failure: a case report

in Multiple Sclerosis and Neuroimmunology

Jing Du
Shugang Cao
Lan Xia
Qi Li
Yanghua Tian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1366725

806 views

Original Research

Published on 15 Jan 2024

Microglia depletion/repopulation does not affect light-induced retinal degeneration in mice

in Multiple Sclerosis and Neuroimmunology

Nils Laudenberg
Urbanus Muthai Kinuthia
Thomas Langmann

Frontiers in Immunology

doi 10.3389/fimmu.2023.1345382

3,422 views
5 citations

Editorial

Published on 11 Jan 2024

Editorial: The molecular basis of programmed cell death and neuroinflammation in neurodegenerative diseases

in Multiple Sclerosis and Neuroimmunology

Chetna Soni
Antariksh Tyagi
Xusheng Wang
Ramkumar Mathur

Frontiers in Immunology

doi 10.3389/fimmu.2023.1359136

1,132 views
1 citation

Original Research

Published on 11 Jan 2024

Single cell sequencing revealed the mechanism of CRYAB in glioma and its diagnostic and prognostic value

in Multiple Sclerosis and Neuroimmunology

Hua-Bao Cai
Meng-Yu Zhao
Xin-Han Li
Yu-Qing Li
Tian-Hang Yu
Cun-Zhi Wang
Li-Na Wang
Wan-Yan Xu
Bo Liang
Yong-Ping Cai

Frontiers in Immunology

doi 10.3389/fimmu.2023.1336187

6,644 views
6 citations

Original Research

Published on 08 Jan 2024

Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD

in Multiple Sclerosis and Neuroimmunology

Lei Wang
Ruihong Xia
Xiangliang Li
Jingli Shan
Shengjun Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1293100

2,732 views
2 citations

Editorial

Published on 05 Jan 2024

Editorial: Epstein-Barr Virus and multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Gunnar Houen
Klemens Ruprecht

Frontiers in Immunology

doi 10.3389/fimmu.2023.1330181

2,061 views

Editorial

Published on 19 Dec 2023

Editorial: Innovative OMICs-technology applications to reach a diagnosis and bring new therapies to immune-mediated neurological diseases

in Multiple Sclerosis and Neuroimmunology

Laura Otero-Ortega
Mireya Fernández-Fournier
Haritz Irizar
David Otaegui
Exuperio Díez-Tejedor

Frontiers in Immunology

doi 10.3389/fimmu.2023.1348986

803 views
1 citation

Brief Research Report

Published on 19 Dec 2023

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study

in Multiple Sclerosis and Neuroimmunology

Harald Hegen
Klaus Berek
Paola Cavalla
Mikael Christiansen
Andreja Emeršič
Massimiliano Di Filippo
Lorenzo Gaetani
Michaela Hassler
Cyra Leurs
Dejan Milosavljevic

Frontiers in Immunology

doi 10.3389/fimmu.2023.1327947

3,474 views
7 citations

Original Research

Published on 13 Dec 2023

Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing–remitting multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Ivan Arisi
Leonardo Malimpensa
Valeria Manzini
Rossella Brandi
Tommaso Gosetti di Sturmeck
Chiara D’Amelio
Sebastiano Crisafulli
Gina Ferrazzano
Daniele Belvisi
Francesca Malerba

Frontiers in Immunology

doi 10.3389/fimmu.2023.1234869

3,174 views
5 citations

Original Research

Published on 12 Dec 2023

Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China

in Multiple Sclerosis and Neuroimmunology

Teng Huang
Fei Liu
Baojie Wang
Chunjuan Wang
Maolin Hao
Shougang Guo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1213532

3,182 views
7 citations

Case Report

Published on 08 Dec 2023

Case Report: Anti-mGluR5 antibody-negative Ophelia syndrome with failed lymph node biopsy due to steroid therapy

in Multiple Sclerosis and Neuroimmunology

Yui Sanpei
Masahito Miura
Homare Funasaka
Akira Hanazono
Sachiko Kamada
Masashiro Sugawara

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188154

1,939 views

Correction

Published on 08 Dec 2023

Corrigendum: Treatment of surgical brain injury by immune tolerance induced by peripheral intravenous injection of biotargeting nanoparticles loaded with brain antigens

in Multiple Sclerosis and Neuroimmunology

Zhen Tian
Lixia Xu
Qian Chen
Ruoyang Feng
Hao Lu
Huajun Tan
Jianming Kang
Yinsong Wang
Hua Yan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1335541

687 views

Original Research

Published on 05 Dec 2023

Biological analysis of the potential pathogenic mechanisms of Infectious COVID-19 and Guillain-Barré syndrome

in Multiple Sclerosis and Neuroimmunology

Hongyu Gao
Shuning Wang
Hanying Duan
Yushi Wang
Hui Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1290578

2,622 views
3 citations

Original Research

Published on 04 Dec 2023

Causal relationships between susceptibility and severity of COVID-19 and neuromyelitis optica spectrum disorder (NMOSD) in European population: a bidirectional Mendelian randomized study

in Multiple Sclerosis and Neuroimmunology

Shengnan Wang
Lijuan Wang
Jianglong Wang
Mingqin Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1305650

3,443 views
6 citations

Case Report

Published on 01 Dec 2023

Case Report: Extraocular muscles paralysis associated with GAD65 antibody: a case series study

in Multiple Sclerosis and Neuroimmunology

Heyu Zhang
Jiajia Yue
Chun Lian
Youming Long
Dan He

Frontiers in Immunology

doi 10.3389/fimmu.2023.1256089

2,166 views

Review

Published on 30 Nov 2023

The role of midkine in health and disease

in Multiple Sclerosis and Neuroimmunology

Emely Elisa Neumaier
Veit Rothhammer
Mathias Linnerbauer

Frontiers in Immunology

doi 10.3389/fimmu.2023.1310094

7,848 views
11 citations